These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2501855

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 8. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha.
    Gyetko MR, Shollenberger SB, Sitrin RG.
    J Leukoc Biol; 1992 Mar; 51(3):256-63. PubMed ID: 1311745
    [Abstract] [Full Text] [Related]

  • 9. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators.
    Sitter T, Toet K, Fricke H, Schiffl H, Held E, Kooistra T.
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1256-63. PubMed ID: 8945961
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a plasminogen activator and its inhibitor in human mesangial cells.
    Lacave R, Rondeau E, Ochi S, Delarue F, Schleuning WD, Sraer JD.
    Kidney Int; 1989 Mar; 35(3):806-11. PubMed ID: 2496257
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lipopolysaccharide-induced modulation of human monocyte urokinase production and activity.
    Manchanda N, Schwartz BS.
    J Immunol; 1990 Dec 15; 145(12):4174-80. PubMed ID: 2258614
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fibrinogenolysis in thrombotic thrombocytopenic purpura.
    Kakishita E, Koyama T, Higuchi M, Kunitomi O, Oura Y, Nagai K.
    Am J Hematol; 1989 Sep 15; 32(1):14-9. PubMed ID: 2502913
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor (TNF) stimulates plasminogen activator inhibitor (PAI) production by endothelial cells and decreases blood fibrinolytic activity in the rat.
    Dosne AM, Dubor F, Lutcher F, Parant M, Chedid L.
    Thromb Res Suppl; 1988 Sep 15; 8():115-22. PubMed ID: 3144762
    [Abstract] [Full Text] [Related]

  • 20. Urinary procoagulant and fibrinolytic activity in human glomerulonephritis. Relationship with renal function.
    Colucci M, Semeraro N, Montemurro P, Chiumarulo P, Triggiani R, Morrone LF, Schena FP.
    Kidney Int; 1991 Jun 15; 39(6):1213-7. PubMed ID: 1910125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.